What is Elevance Health's expected EPS for Q2 2026?

Analysts expect Elevance Health (ELV) to report consensus EPS of approximately $6.21 for Q2 2026. Estimates range from $6.06 to $6.73.

What revenue do analysts expect for Elevance Health in Q2 2026?

The consensus revenue forecast for Elevance Health (ELV) in Q2 2026 is approximately $48.6B. Forecasts range from $47.6B to $49.6B.

How many analysts cover Elevance Health?

19 analysts contribute to the Elevance Health (ELV) Q2 2026 consensus estimate.

Has Elevance Health beaten earnings estimates recently?

Elevance Health beat analyst EPS estimates in 3 of the last 3 quarters. Elevance Health beat revenue estimates in 2 of 3. In the most recent quarter (Q2 2026), Elevance Health EPS beat by 19.9% and revenue beat by 1.9%.

When does Elevance Health report Q2 2026 earnings?

Elevance Health (ELV) is expected to report Q2 2026 earnings on July 15, 2026 before market open.

ELV Q2 2026 earnings estimate

Consensus EPS · Q2 2026

$6.21

Consensus revenue · Q2 2026

$48.6B

Analysts

Last reported

Jul 15, 2026

Before open

Results are in

XP scoring in progress…

Revenue actual$49.8B

Revenue consensus$48.9B

EPS actual$7.45

EPS consensus$6.21

Revenue surprise: +1.94%EPS surprise: +19.97%

Analyst consensus

Based on estimates from 19 analysts.

Metric	Low	Consensus	High
Revenue	$47.6B	$48.6B	$49.6B
EPS	$6.06	$6.21	$6.73
EBITDA	$2.9B	$3B	$3.1B
EBIT	$2.5B	$2.5B	$2.6B
Net income	$1.3B	$1.4B	$1.4B

Revenue$48.6B
EPS$6.21
EBITDA$3B
EBIT$2.5B
Net income$1.4B

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

Period	Rev. actual	Rev. est.	Rev. surprise	EPS actual	EPS est.	EPS surprise
Q2 2026	$49.8B	$48.9B	+1.9%	$7.45	$6.21	+19.9%
Q1 2026	$49.5B	$48.2B	+2.7%	$12.58	$10.82	+16.3%
Q4 2025	$49.3B	$49.8B	-1.1%	$3.33	$3.10	+7.5%

Q2 2026+1.9%+19.9%
Q1 2026+2.7%+16.3%
Q4 2025-1.1%+7.5%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

No community consensus

No TickerLeague members predicted Elevance Health (ELV) Q2 2026 before it reported.

Analyst price target

Based on price targets from 14 analysts.

Low: $391.00
Consensus: $440.17
Median: $452.50
High: $498.00
Current: $389.09
Upside: +13.1%

Upside calculated vs most recent trading price of $389.09.

Consensus across all covering analysts. See the ranking ›

$440.17+13.13%

Analyst ratings

Consensus: Buy — based on 38 analyst ratings.

Buy 27Hold 11

24-month trend

Recent analyst actions

Date	Firm	Action	From	To
Jul 17, 2026	Leerink Partners	maintain	Market Perform	Market Perform
Jul 16, 2026	Wells Fargo	maintain	Overweight	Overweight
Jul 16, 2026	RBC Capital	maintain	Sector Perform	Sector Perform
Jul 16, 2026	Guggenheim	maintain	Buy	Buy
Jul 16, 2026	Barclays	maintain	Overweight	Overweight
Jul 16, 2026	Baird	maintain	Neutral	Neutral
Jul 14, 2026	Truist Securities	maintain	Buy	Buy
Jul 14, 2026	TD Cowen	maintain	Buy	Buy
Jul 13, 2026	Wells Fargo	maintain	Overweight	Overweight
Jul 9, 2026	RBC Capital	maintain	Sector Perform	Sector Perform

Jul 17, 2026Leerink PartnersMarket Perform
Jul 16, 2026Wells FargoOverweight
Jul 16, 2026RBC CapitalSector Perform
Jul 16, 2026GuggenheimBuy
Jul 16, 2026BarclaysOverweight
Jul 16, 2026BairdNeutral
Jul 14, 2026Truist SecuritiesBuy
Jul 14, 2026TD CowenBuy
Jul 13, 2026Wells FargoOverweight
Jul 9, 2026RBC CapitalSector Perform

Frequently asked questions

Elevance Health (ELV) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

ELV Overview

Counters

Income Statement

Cash Flow

Capital Return

How this company returns cash to shareholders — buybacks, dividends, and stock splits.

Forecast & Valuation